rs1139266

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018389.5(SLC35C1):​c.*49G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.71 in 1,424,788 control chromosomes in the GnomAD database, including 373,827 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 29836 hom., cov: 33)
Exomes 𝑓: 0.73 ( 343991 hom. )

Consequence

SLC35C1
NM_018389.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.197

Publications

25 publications found
Variant links:
Genes affected
SLC35C1 (HGNC:20197): (solute carrier family 35 member C1) This gene encodes a GDP-fucose transporter that is found in the Golgi apparatus. Mutations in this gene result in congenital disorder of glycosylation type IIc. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
SLC35C1 Gene-Disease associations (from GenCC):
  • leukocyte adhesion deficiency type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 11-45811384-G-A is Benign according to our data. Variant chr11-45811384-G-A is described in ClinVar as Benign. ClinVar VariationId is 261026.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.755 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC35C1NM_018389.5 linkc.*49G>A 3_prime_UTR_variant Exon 2 of 2 ENST00000314134.4 NP_060859.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC35C1ENST00000314134.4 linkc.*49G>A 3_prime_UTR_variant Exon 2 of 2 1 NM_018389.5 ENSP00000313318.3
SLC35C1ENST00000442528.2 linkc.*49G>A 3_prime_UTR_variant Exon 3 of 3 1 ENSP00000412408.2
SLC35C1ENST00000526817.2 linkc.*49G>A 3_prime_UTR_variant Exon 3 of 3 2 ENSP00000432145.2

Frequencies

GnomAD3 genomes
AF:
0.576
AC:
87521
AN:
151996
Hom.:
29830
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.206
Gnomad AMI
AF:
0.787
Gnomad AMR
AF:
0.635
Gnomad ASJ
AF:
0.794
Gnomad EAS
AF:
0.330
Gnomad SAS
AF:
0.655
Gnomad FIN
AF:
0.737
Gnomad MID
AF:
0.715
Gnomad NFE
AF:
0.760
Gnomad OTH
AF:
0.606
GnomAD2 exomes
AF:
0.631
AC:
44783
AN:
71026
AF XY:
0.639
show subpopulations
Gnomad AFR exome
AF:
0.196
Gnomad AMR exome
AF:
0.640
Gnomad ASJ exome
AF:
0.809
Gnomad EAS exome
AF:
0.340
Gnomad FIN exome
AF:
0.726
Gnomad NFE exome
AF:
0.760
Gnomad OTH exome
AF:
0.685
GnomAD4 exome
AF:
0.726
AC:
923808
AN:
1272674
Hom.:
343991
Cov.:
23
AF XY:
0.726
AC XY:
449975
AN XY:
619382
show subpopulations
African (AFR)
AF:
0.182
AC:
5133
AN:
28226
American (AMR)
AF:
0.635
AC:
12772
AN:
20102
Ashkenazi Jewish (ASJ)
AF:
0.800
AC:
15083
AN:
18860
East Asian (EAS)
AF:
0.312
AC:
11053
AN:
35424
South Asian (SAS)
AF:
0.679
AC:
42902
AN:
63152
European-Finnish (FIN)
AF:
0.704
AC:
21589
AN:
30664
Middle Eastern (MID)
AF:
0.738
AC:
2643
AN:
3582
European-Non Finnish (NFE)
AF:
0.761
AC:
775754
AN:
1019550
Other (OTH)
AF:
0.694
AC:
36879
AN:
53114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
12691
25383
38074
50766
63457
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19240
38480
57720
76960
96200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.576
AC:
87550
AN:
152114
Hom.:
29836
Cov.:
33
AF XY:
0.576
AC XY:
42811
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.206
AC:
8544
AN:
41502
American (AMR)
AF:
0.635
AC:
9711
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.794
AC:
2753
AN:
3468
East Asian (EAS)
AF:
0.329
AC:
1688
AN:
5134
South Asian (SAS)
AF:
0.654
AC:
3155
AN:
4826
European-Finnish (FIN)
AF:
0.737
AC:
7803
AN:
10584
Middle Eastern (MID)
AF:
0.714
AC:
210
AN:
294
European-Non Finnish (NFE)
AF:
0.760
AC:
51682
AN:
67994
Other (OTH)
AF:
0.609
AC:
1286
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1478
2956
4434
5912
7390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.699
Hom.:
69143
Bravo
AF:
0.551
Asia WGS
AF:
0.525
AC:
1828
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Leukocyte adhesion deficiency type II Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.7
DANN
Benign
0.57
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1139266; hg19: chr11-45832935; COSMIC: COSV58480616; COSMIC: COSV58480616; API